The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching
8d agoen
From the article
Conditions : Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Atopic Dermatitis (AD) Interventions : Drug: Upadacitinib 15 MG Sponsors : RenJi Hospital Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Four JAK Inhibitors Show Positive Late-Stage Trial Results for Axial Spondyloarthritis Treatment
Positive results from late-stage clinical trials of four JAK inhibitors (filgotinib, gecacitinib, ivarmacitinib, and tofacitinib) for treati
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
doi.org·13d ago
Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus
This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce
Soluble bacterial lipopeptides suppress gasdermin D-associated IL-33 release in keratinocytes and atopic dermatitis in mice
doi.org·21d ago
Systematic review of metastatic Crohn's disease: clinical features, demographics, and treatment approaches
This systematic review examines metastatic Crohn's disease (MCD), a rare cutaneous manifestation of Crohn's disease. Analyzing 230 studies c
Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
doi.org·20d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.